SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001750019-19-000025
Filing Date
2019-04-12
Accepted
2019-04-12 16:09:00
Documents
1
Period of Report
2019-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155509972563704.html 4  
1 FORM 4 wf-form4_155509972563704.xml 4 3926
  Complete submission text file 0001750019-19-000025.txt   5298
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Cardama Alfonso Quintas (Reporting) CIK: 0001760104 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38811 | Film No.: 19746379